0000950170-24-059543.txt : 20240514 0000950170-24-059543.hdr.sgml : 20240514 20240514161019 ACCESSION NUMBER: 0000950170-24-059543 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240513 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240514 DATE AS OF CHANGE: 20240514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 24944410 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 8-K 1 awh-20240513.htm 8-K 8-K
false000092661700009266172024-05-132024-05-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 13, 2024

 

 

Aspira Women’s Health Inc.

(Exact name of registrant as specified in its charter)

 

 





 

 

Delaware

001-34810

33-0595156

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)





 

 

 

12117 Bee Caves Road, Building III, Suite 100, Austin, Texas

 

78738

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (512) 519-0400



 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:



 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)



 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)





 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))





 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



 

 

Securities registered pursuant to Section 12(b) of the Act:





 

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

AWH

Nasdaq Capital Market



Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).



Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 13, 2024, Aspira Women’s Health Inc. (the “Company”) held its 2024 annual meeting of stockholders (the “Annual Meeting”). As of the close of business on the record date for the Annual Meeting, there were 12,344,104 shares of the Company’s common stock, par value $0.001 per share, issued and outstanding and entitled to vote. There were 8,093,336 shares present in person or by proxy at the Annual Meeting, constituting a quorum. The final voting results were as follows:

 

Proposal 1: Election of Directors

The Company’s stockholders elected each of the Company’s six nominees for director for a one-year term expiring at the Company’s 2025 annual meeting of stockholders and until their successors are elected and qualified, as set forth below:

 

 

 

 

 



NOMINEE

FOR

AGAINST

ABSTENTIONS

BROKER NON-VOTES

Stefanie Cavanaugh

4,213,732

69,683

5,564

3,804,357

Celeste R. Fralick, Ph.D.

4,220,435

67,647

897

3,804,357

Jannie Herchuk

4,210,555

72,860

5,564

3,804,357

Lynn O’Connor Vos

4,215,103

72,978

898

3,804,357

Nicole Sandford

4,183,242

93,278

12,459

3,804,357

Winfred Parnell, M.D.

4,214,222

73,859

898

3,804,357

 

Proposal 2: Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 1, 2024, as set forth below:

 

 

 

 

 

FOR

AGAINST

ABSTENTIONS

BROKER NON-VOTES

4,189,574

97,653

1,752

3,804,357

 

Proposal 3: Approval of an Amendment to the Aspira Women’s Health Inc. 2019 Stock Incentive Plan

The Company’s stockholders approved an amendment to the Company’s 2019 Stock Incentive Plan (the “2019 Plan”) to increase the number of shares of common stock authorized to be granted under the 2019 Plan by 1,000,000 shares and increase the maximum number of awards that may be granted as incentive stock options under the 2019 Plan to a total of 3,000,000 shares, as set forth below:

 

 

 

 



FOR

AGAINST

ABSTENTIONS

BROKER NON-VOTES

4,187,597

98,942

2,440

3,804,357

 

Proposal 4: Ratification of the Selection of the Company’s Independent Registered Public Accounting Firm

The Company’s stockholders ratified the selection of BDO USA, LLP (n/k/a BDO P.C.) as the Company’s independent registered public accounting firm for the year ending December 31, 2024, as set forth below:

 

 

 

 

 

FOR

AGAINST

ABSTENTIONS

BROKER NON-VOTES

7,992,912

88,066

12,358

 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

 

Exhibit No.

Description

104

Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

 

 



 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.





 

 

 



 

 



 

ASPIRA WOMEN’S HEALTH INC.



 

 

Date: May 14, 2024

By:

/s/ Torsten Hombeck



 

Torsten Hombeck



 

Chief Financial Officer

 





 

 EX-101.SCH 2 awh-20240513.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Entity Address, State or Province Entity Address, State or Province Trading Symbol Trading Symbol Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Written Communications Written Communications Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Registrant Name Entity Registrant Name Entity Address, Address Line Three Entity Address, Address Line Three Document Period End Date Document Period End Date Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Incorporation State Country Code Entity Incorporation State Country Code Local Phone Number Local Phone Number City Area Code City Area Code Pre Commencement Tender Offer Pre Commencement Tender Offer Cover [Abstract] Cover [Abstract] Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag Entity File Number Entity File Number Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Security 12b Title Security 12b Title Document Type Document Type XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document and Entity Information
May 13, 2024
Cover [Abstract]  
Entity Registrant Name Aspira Women’s Health Inc.
Security Exchange Name NASDAQ
Amendment Flag false
Entity Central Index Key 0000926617
Document Type 8-K
Document Period End Date May 13, 2024
Entity Incorporation State Country Code DE
Entity File Number 001-34810
Entity Tax Identification Number 33-0595156
Entity Address, Address Line One 12117 Bee Caves Road
Entity Address, Address Line Two Building III
Entity Address, Address Line Three Suite 100
Entity Address, City or Town Austin
Entity Address, State or Province TX
Entity Address, Postal Zip Code 78738
City Area Code (512)
Local Phone Number 519-0400
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.001 per share
Trading Symbol AWH
Entity Emerging Growth Company false
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports awh-20240513.htm awh-20240513.xsd http://xbrl.sec.gov/dei/2023 false false JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "awh-20240513.htm": { "nsprefix": "awh", "nsuri": "http://aspirawh.com/20240513", "dts": { "inline": { "local": [ "awh-20240513.htm" ] }, "schema": { "local": [ "awh-20240513.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_b5edd3f7-3b24-407c-9643-713d8c2f8699", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "awh-20240513.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_b5edd3f7-3b24-407c-9643-713d8c2f8699", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "awh-20240513.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://aspirawh.com/20240513/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 12 0000950170-24-059543-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-059543-xbrl.zip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

XML 14 awh-20240513_htm.xml IDEA: XBRL DOCUMENT 0000926617 2024-05-13 2024-05-13 false 0000926617 8-K 2024-05-13 Aspira Women’s Health Inc. DE 001-34810 33-0595156 12117 Bee Caves Road Building III Suite 100 Austin TX 78738 (512) 519-0400 false false false false Common Stock, par value $0.001 per share AWH NASDAQ false